Key Highlights

  • Molina Healthcare (NYSE:MOH) reported third-quarter GAAP earnings of USD 0.73 per share on Wednesday, October 21, 2026, down 52% from USD 1.51, while total revenue of USD 11.08 billion topped estimates.
  • The consolidated medical care ratio rose to 92.9% from 92.6%, driven by Medicaid at 93.0% against 92.0% a year earlier, while the Marketplace ratio improved by 310 basis points.
  • Membership fell about 13.6% to 4.86 million, with Marketplace enrolment down to 267,000 from 713,000 as the insurer shrank its exposure to individual exchange plans.
  • Full-year 2026 guidance of at least USD 5.25 in adjusted EPS was reaffirmed, and it absorbs about USD 2.50 per share of losses from a new Florida contract and an exited Medicare product.

A Revenue Beat With Half the Profit

Molina Healthcare (NYSE:MOH), a managed care company focused on government-sponsored health plans, released third-quarter results on Wednesday, October 21, 2026. Total revenue was USD 11.08 billion, down about 3% from USD 11.48 billion, but above consensus estimates. Premium revenue fell 4% to USD 10.46 billion. GAAP net income dropped 52% to USD 38 million, or USD 0.73 per share, while adjusted EPS fell 53% to USD 0.89 from USD 1.84. The consolidated medical care ratio rose to 92.9% from 92.6%. Membership fell to 4.86 million from 5.63 million a year earlier. The shares dipped after the release, with market data showing declines of about 4%. Management held a conference call at 8:00 a.m. ET on Thursday, October 22, 2026.

Why the Medical Care Ratio Drives the Stock

For Molina Healthcare (NYSE:MOH), the medical care ratio, the share of premiums paid out in medical claims, is the core profit lever. With an adjusted administrative cost ratio of 6.3%, a consolidated ratio of 92.9% leaves, on simple arithmetic, under one cent of margin per premium dollar before investment income, so a 30 basis point rise can cut earnings sharply. Medicaid, about 4.37 million of the 4.86 million members, ran at 93.0%, 100 basis points worse than a year earlier. Marketplace improved to 92.5% from 95.6%, and Medicare eased to 93.0% from 93.6%. Chief executive Joseph Zubretsky said Molina was "likely observing the beginning of the turn in Medicaid margins", citing 2027 rate updates, which states set to reflect recent cost trends.

Risks and What to Watch

The main risk for Molina Healthcare (NYSE:MOH) is that Medicaid rate updates for 2027 lag cost trend, which would keep the segment ratio near 93%. The second is execution on the new Florida Medicaid contract, which the company expects to cost about USD 1.50 per share in the fourth quarter. The third is the exit from the traditional Medicare Advantage prescription drug product for 2027, which is guided at about USD 1.00 per share of loss this year. Parent company cash of about USD 608 million, up from USD 223 million at the end of 2025, gives some cushion. Investors should watch the Fed decision on Wednesday, October 28, 2026, the midterm elections on Tuesday, November 3 and Medicare enrolment closing on Monday, December 7.

Where Things Stand

The answer is that Molina Healthcare (NYSE:MOH) dipped because a revenue beat could not offset a 52% fall in GAAP earnings, driven by a Medicaid cost ratio of 93.0%. The reaffirmed floor of USD 5.25 in adjusted EPS and the call for a Medicaid margin turn in 2027 limit the damage. The next catalysts are the Fed decision on October 28, the midterm elections on November 3 and state rate updates for 2027. Guidance is a company forecast, not a guarantee, and this is not investment advice.